Thursday, April 28, 2016

Tech Q&A: CTO of Gopher Protocol (OTCQB: GOPH) Explains How the Guardian Patch Could Potentially Save Your Life

Tech Q&A: CTO of Gopher Protocol (OTCQB: GOPH) Explains How the Guardian Patch Could Potentially Save Your Life

New Mobile Tracking Tech Will Track and Protect Anything You Care About; With or Without GPS


PERRIS, California, Point Roberts WA, April 28, 2016 - Investorideas.com , a global news source covering tech stocks interviews Danny Rittman, CTO of  Gopher Protocol Inc. (OTCQB:GOPH) to learn about its licensed technology, the Guardian Patch, aiming to hit consumer markets in 2017.
   
The Guardian Patch, under development, is a unique location technology that works with or without GPS. It is a stick-on tracking device that protects and tracks everything from a phone to a loved- one or a pet. Danny shares its history, current status and how the Guardian Patch could potentially save your life in the future.



Q: Investorideas.com: Danny, for investors that have no previous knowledge of your company and technology can briefly you tell us the history of the Guardian Patch and how your company came to license this technology?

A: Danny Rittman, CTO – The Guardian Patch device was born as a derivative of our microchip technology called GopherInsight™. Gopher Protocol is developing under exclusive license granted by me, mobile, intelligent technology that connects mobile devices via its private, secured communication protocol in order to provide advanced features. The Guardian Patch is based on that technology. Each Guardian Patch device is connected to all others via its private, secured protocol. The device is affixed onto objects, mobile or static and once affixing, starts its operation as a tracking device.

The user installs the Guardian app in order to track the Guardian Patch via mapping feature. The Guardian Patch uses GPS coordinates when GPS services are available. In places where GPS services are not available, it automatically switches to its own proprietary based technology in order to obtain its geographical location and send it through its network. For the user these activities are transparent. The Guardian Patch geographical location is shown on Google/Yahoo/Bing map regardless which method is used.

One Guardian Patch can be registered on multiple apps via its ID. In this way, multiple users can view a location of an object(s).

The Guardian Patch also works as an Emergency beacon. Upon detaching, it start transmitting Emergency signal about its location to all apps that it is registered on.

The Guardian Patch is designed to function for one full year. Upon detaching and functioning as an Emergency beacon, the Patch will constantly transmit its location until exhausting its battery life same as aircraft’s black boxes system.


Q: Investorideas.com: Can you explain how the Guardian Patch tracking works?

A: Danny Rittman, CTO – The Guardian Patch uses GPS coordinates when GPS services are available. In places where GPS services are not available, it automatically switches to its own proprietary based technology to obtain its geographical location and sending it through its network. For the user these activities are transparent. All he/she sees is the moving dot of the object on Guardian mapping app. The system is based among other confidential features on a proprietary RF (Radio Frequency) technology and ultimately providing worldwide coverage. The main advantage of the system is the fact that it is conventional-network independent. It does not require conventional network like Wi-Fi, Bluetooth or others.


Q: Investorideas.com: And what about the pull- off emergency sticker in case of emergency?

A: Danny Rittman, CTO - The Guardian Patch also works as an Emergency beacon. Upon detaching, it starts transmitting Emergency signal about its location to all apps that it is registered on. Typically the Guardian Patch transmits its location every few minutes but in the Emergency beacon mode it will constantly transmit its geographical location until exhausting its power source, similar to aircraft’s black box. The system has reserved power source just for emergency beacon purposes in order to ensure constant Emergency transmission for about 2-3 weeks. It can save lives!


Q: Investorideas.com: Can you explain how the Guardian Patch works with or without GPS and how that is a game-changer?

A: Danny Rittman, CTO - The Guardian Patch detects when a GPS services exist and then acquire its geographical location. These coordinates are transmitted via its proprietary Radio technology to the user’s mobile app to be presented on Guardian mapping app. If GPS services are not available due to topological conditions, for example, caves, tunnels, closed locations, the system automatically switches to its proprietary radio system in order to calculate and provide its location. Our technology works in most obscure topographical locations like underwater, underground and even outer space.


Q: Investorideas.com: Can you tell us the current status and development and what is needed next to bring it to market?

A: Danny Rittman, CTO - The Guardian Patch is currently in the hardware and software implementation stage. In parallel we are working on the product’s logistics of packaging, mass production and distribution. We aim to release commercial full first generation by Easter of 2017.


Q: Investorideas.com: Is there anything out in the marketplace like the Guardian Patch?  What makes this truly unique?

A: Danny Rittman, CTO - The Guardian Patch is the first technology of its kind. There are GPS based vehicles and many, short range, Bluetooth based, tracking devices in the market today. The tracking devices which using GPS are limited and need to have “clear skies” above. They are also require complicate installation and costly. The short-range, Bluetooth based devices can provide short range (Few dozen feet) tracking only. The Guardian Patch is the first and the only device that is not GPS-dependent or Bluetooth and provides long range coverage. Its price is affordable and its size/shape make him perfect device to be used for many tracking applications. Users can use it to track vehicles, small or large valuables and virtually anything!

About Gopher Protocol Inc. Gopher Protocol Inc. (OTCQB: GOPH) (“Gopher” and the "Company") (http://gopherprotocol.com/) is a development-stage company developing a real-time, heuristic based, mobile technology, per license agreement it holds. Upon development, the technology will consist of a smart microchip, mobile application software and supporting software that run on a server.  The system contemplates the creation of a global network, worldwide. Gopher believes this will be the first system that is developed using a human, heuristic based analysis engine. Since the core of the system will be its advanced microchip that will be able to be installed any mobile device, worldwide, Gopher expects that this will result in an internal, private network between all mobile devices utilizing the device by providing mobile technology for computing power enhancement, advanced mobile database management/sharing, and additional mobile features.

About Investorideas.com - Global news source covering leading sectors including technology.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Contact Investorideas.com 800 665 0411

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GOPH is a PR , social media and publishing client and compensates Investorideas.com ( three months effective April 4, 2016 - three thousand five hundred per month )More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.




Q BioMed Inc (OTCQB: $QBIO) CEO Pens Management Piece Featured in Life Science Leader

Q BioMed Inc (OTCQB: $QBIO) CEO Pens Management Piece Featured in Life Science Leader


NEW YORK - April 28, 2016 (Investorideas.com Newswire) Q BioMed Inc. (OTC: QBIO), a biotechnology acceleration company reports the Company's CEO was featured in an article he wrote on venture capital titled Accelerators Enter When VCs Fear To Tread:

Life Science Leader magazine is an essential business journal for life science executives who work for everything from emerging biotechs to Big Pharmas. Their content is designed to inform readers of industry best practices and motivate them to implement those practices in their businesses.

Each month, Life Science Leader features interviews with executives from the leading pharma and biotech companies, including Pfizer, Merck, Daiichi Sankyo, Genentech, Genzyme, Eli Lilly, and Janssen, as well as the FDA and more. This exclusive thought leadership provides an in-depth look into industry trends and hot topics that will impact the growth of the pharma and biopharma markets. As the market is continually growing and innovating, these insights provide readers with actionable information and strategies to implement when navigating the evolving clinical, manufacturing, entrepreneurial, and regulatory landscapes.

Corin explains how times have changed for start-up biotechnology companies, though, and the challenges have grown in magnitude. These days, the very same venture capital firms that would hand out a few dollars in the early stages now are idling their time, investing much bigger sums only after much more development has occurred.

In the article, Corin leverages his expertise at Q BioMed Inc., where he focuses on acquiring licenses to innovative biomedical assets in the private company space or academic setting.
"Our team at Q Bio are dedicated to providing those developers with the strategic resources, developmental support, and expansion capital to ensure they meet their potential, with the ultimate goal of enabling them to provide products to patients in need. Our mission is to license and acquire innovative life sciences assets and accelerate their product development timelines to commercialize their drug candidates and devices or bring them to the next level in terms of valuation inflection and the attention of the larger Pharma players or IPO them as stand-alone companies or just grow a revenue model organically", states Corin.

Excerpt from the article:
"Most venture funds, for example, have become increasingly impatient to harvest returns from their investments, many expecting an 'exit' within only 2-4 years. This trend has been adverse for many biomedical technologies, since they generally have a much longer gestation cycle than communications, electronics or information technologies. In addition, many biomedical technologies require regulatory approvals, which further increases development costs and lengthens the investment cycle."

The one thing that really has not changed is the amount of equity the venture capitalists want when they finally do invest. For those who are only interested in getting their idea into the marketplace, giving up 80 or 90% of their company may be acceptable. Jonas Salk refused to patent his polio vaccine because his focus was preventing that disease and not making billions for himself. Handing off the headaches of running a business to people who studied accounting and marketing rather than organic chemistry and electrical engineering may be the solution for many researchers.

To read the entire article, please follow this link

About Q BioMed Inc.
Q BioMed Inc. ”Q“ is a biomedical acceleration and development company. We are focused on acquiring companies and biomedical assets. Q is dedicated to providing these target companies and assets, strategic resources, developmental support, and expansion capital to ensure they meet their developmental potential enabling them to provide products to patients in need.


Forward-Looking Statements:
This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to our growth strategy and product development programs and any other statements that are not historical facts. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: risks related to our growth strategy; risks relating to the results of research and development activities; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; uncertainties relating to preclinical and clinical testing; our dependence on third-party suppliers; our ability to attract, integrate, and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

Contact:
Denis Corin
CEO
Q BioMed Inc.
1 888 357 2435 

Visit this Company: http://www.qbiomed.com

More info on QBIO at Investorideas.com: http://www.investorideas.com/CO/QBIO/

Sign up for the free investor news and stock alerts:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Disclosure: QBIO has retained investorideas.com for PR, media, news publication and social media effective February 5th for three months: two thousand five hundred per month.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info:
http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.






Tuesday, April 26, 2016

NXT-ID (NASDAQ: $NXTD) Announces Gregory M. Johnson, Head of Business Relationships for Capital One (NYSE: $COF) Joins Advisory Board

NXT-ID (NASDAQ: $NXTD) Announces Gregory M. Johnson, Head of Business Relationships for Capital One (NYSE: $COF) Joins Advisory Board

Company Continues to Build's its Team of Financial Services and Retail Experts to Maximize NXT-ID's Disruptive Technologies



MELBOURNE, Fla. - April 26, 2016 (Investorideas.com Newswire) NXT-ID, Inc. (NASDAQ:NXTD), a company focused on the growing mobile commerce market announces that Mr. Gregory M. Johnson has been appointed to its Board of Directors.

Gregory is currently Head of Business Relationships for Capital One and is leading a B2B growth strategy that includes building out new high touch dialogic channels and partnerships that attract and grow relationships with small businesses and mid-market companies in the US.

Prior to joining Capital One, Gregory spent 17 years at American Express Company working in Consulting Services, Business Travel, Commercial Card, and the OPEN Small Business brand forming strategy and architecting large client facing teams to acquire and grow customers through various channels.

Gregory earned his Bachelor's degree in Business Administration and Marketing from Arizona State University and went on to complete his Executive MBA.

Gino Pereira, Chief Executive Officer, said," Gregory's current expertise and experience in the financial payment space brings a fresh perspective to Nxt-ID's strategic planning. We have a formidable team of Directors and advisors to maximize growth for the Company."
Gregory M. Johnson said, "I'm excited to be joining the Advisory Board of Nxt-ID at a time when there is so much disruption and opportunity in the payment space. I believe that the Company's technologies are well suited to the future direction of mobile payments and that I look forward to contributing to the Company's growth prospects."

Gregory joins a notable advisory board consisting of:
Mr William Fields is currently the Chairman of Fields Texas Limited LLC (a private investment and retail advisory firm) and Four Corners Sourcing LLC. In his twenty-five-year career at Wal-Mart Inc., Mr. Fields held various executive positions, which included Assistant to Sam Walton (Founder of Wal-Mart Inc.), Senior Vice President of Distribution & Transportation, Executive Vice President of Wal-Mart Inc. and President and CEO of the $68 billion Wal-Mart Retail Stores Division. Mr. Fields was responsible for the strategic planning, execution and oversight for operations, merchandising, marketing and logistics for over 2,000 stores and 700,000 employees.

After Mr. Fields departure from Wal-Mart, he served as Chairman and CEO of Blockbuster Entertainment Group and the President and CEO of Hudson's Bay Company. He currently holds board positions with Lexmark International Inc., Escort Inc., The Joint Corp, General Foam Plastics and Biosara.

Mr. Lawrence Flanagan - President and CEO of AARP Member Services and formerly the Executive Dean at the University of New Haven College of Business. Flanagan is regarded as one of the most accomplished global marketing leaders in the country.

Prior to his career in academia, he spent nearly three decades in corporate America as an executive at MasterCard Worldwide, the Procter & Gamble Company and L'Oreal USA. As the global chief marketing officer at MasterCard, he managed a $1.5 billion budget, directed marketing strategies in more than 50 countries and helped launch the company's hugely successful, "Priceless" advertising campaign. He also established strategic partnerships with Major League Baseball, the PGA Tour and Champions League soccer in Europe and was part of the executive team that spearheaded MasterCard's highly successful initial public offering in 2006.

Mr. Ken Moy - Director of Global Payments and Emerging Commerce at Subway. He was formerly senior vice president and Group Head of US Emerging Payments at MasterCard Worldwide.

Ken has extensive experience in large-scale rollouts, partnerships, corporate development, strategic planning, business administration and product management. He launched MasterPass, the firm's digital wallet solution and important pillar to overall strategy, achieving over 25,000 online merchants, and wallet distribution with over 20 financial institutions. He led an exclusive agreement with Google, Citibank and First Data to launch Google Wallet, the first commercially available mobile payment solutions. He also led an exclusive agreement with Intel for access to embedded technology in Intel PCs to deliver enhanced security and user experience for electronic ecommerce.


About NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID (NASDAQ:NXTD) is an emerging growth technology company that is focused on products, solutions, and services for security on mobile devices. Our core technologies consist of those that support digital payments, biometric identification, encryption, sensors, and miniaturization. We have three distinct lines of business that we are currently pursuing: mobile commerce, primarily through the application of secure digital payment technologies; biometric access control applications, and Department of Defense contracting. Our initial efforts have primarily focused on the development of our secure products for the growing m-commerce market, most immediately, a secure mobile electronic smart wallet, the Wocket®. The Wocket® is a smart wallet, designed to protect your identity. www.nxt-id.com, www.wocketwallet.com

Product images are available for media at: http://press.nxt-id.com

Forward-Looking Statements for NXT-ID: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.

NXT- ID Inc Contact:
Corporate info: info@nxt-id.com

Media:
D. Van Zant
800 665-0411
Visit this company: nxt-id.com; 3d-id.netwocketwallet.com/

More info on NXTD at Investorideas.com Visit: http://www.investorideas.com/CO/NXT/

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Sign up for free news alerts

Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: As of October 1, 2015 NXT-Id renewed for one year –five thousand per month and fifteen thousand 144 restricted shares for PR, media and marketing. http://www.investorideas.com/About/Disclaimer.asp and http://www.investorideas.com/About/News/Clientspecifics.asp


Q BioMed Inc (OTCQB: $QBIO) to Present at the Global Chinese Financial Forum on April 30, 2016

Q BioMed Inc (OTCQB: $QBIO) to Present at the Global Chinese Financial Forum on April 30, 2016

Toronto, ON Conference Expects to Attract Over 200 Participants



NEW YORK - April 26, 2016 (Investorideas.com Newswire) Q BioMed Inc. (OTC: QBIO), a biotechnology acceleration company, today announced that the company will present at the Global Chinese Financial Forum (GCFF). The GCFF is the most prominent series of bi-lingual financial functions in both North America and China. Established in 2000, GCFF's mandate is to provide a world-class platform connecting both the Asian and North American financial markets. GCFF assembles companies, financial institutions and investors who are interested in exploring new investment ideas and financial opportunities.

The conference is being held at the Marriott Courtyard Hotel in Markham, Ontario Canada at 7095 Woodbine Ave, Markham, Ontario.

The conference runs from 9am to 5pm. Q BioMed CEO, Denis Corin, will present at 10:20am.

Organizers expect the conference to attract over 200 participants consisting of pre-qualified investors, industry executives and professional service providers.

For more information or to register as an attendee of the conference, please click HERE.

To stay informed on Q BioMed developments please visit our website http://www.qbiomed.com and sign up for our news distribution.


About GCFF - GLOBAL CHINESE FINANCIAL FORUM
Organized by NAI Interactive, the Global Chinese Financial Forum (GCFF) is the most prominent series of bi-lingual financial functions in both North America and China. Established in 2000, GCFF's mandate is to provide a world-class platform connecting both the Asian and North American financial markets. We assemble companies, financial institutions and investors who are interested in exploring new investment ideas and financial opportunities.

With an extensive network covering both the North American and Chinese market alongside expertise in the global capital market, GCFF is supported by a strong foundation of financial resources. It enables GCFF to organize resourceful financial events that facilitate business growth and networks among financial institutions, public corporations, private companies, and investors of all levels.

In the past 16 years, over 35 GCFF conferences have been held in multiple locations worldwide including Vancouver, Toronto and China. The latest LNG Investment Conference was held in April 2014 to enlighten the Chinese community on the latest LNG development in British Columbia. The conference attracted over 200 participants consisting of pre-qualified investors, industry executives and professional service providers.

About Q BioMed Inc.
Q BioMed Inc. ”Q“ is a biomedical acceleration and development company. We are focused on acquiring companies and biomedical assets. Q is dedicated to providing these target companies and assets, strategic resources, developmental support, and expansion capital to ensure they meet their developmental potential enabling them to provide products to patients in need.

Forward-Looking Statements:
This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to our growth strategy and product development programs and any other statements that are not historical facts. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: risks related to our growth strategy; risks relating to the results of research and development activities; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; uncertainties relating to preclinical and clinical testing; our dependence on third-party suppliers; our ability to attract, integrate, and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

Contact:
Denis Corin
CEO
Q BioMed Inc.
1 888 357 2435 

Visit this Company: http://www.qbiomed.com

More info on QBIO at Investorideas.com: http://www.investorideas.com/CO/QBIO/

Sign up for the free investor news and stock alerts:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Disclosure: QBIO has retained investorideas.com for PR, media, news publication and social media effective February 5th for three months: two thousand five hundred per month.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info:
http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.




Gopher Protocol (OTCQB:$GOPH) to Expand Its Exclusive License IP Portfolio - New Patent for Guardian-LIFE Medical Patch, a Derivative of the Guardian Patch Technology

Gopher Protocol (OTCQB:$GOPH) to Expand Its Exclusive License IP Portfolio - New Patent for Guardian-LIFE Medical Patch, a Derivative of the Guardian Patch Technology



PERRIS, CA - April 26, 2016 (Investorideas.com Newswire) Gopher Protocol Inc. (OTCQB: GOPH) ("Gopher" and the "Company"), a development-stage Company developing a real-time, heuristic based, mobile technology, announced today that Dr. Rittman has applied for a patent for the Guardian-LIFE medical patch technology. If the patent is issued, Dr. Rittman will assign the patent to Guardian Patch LLC, the Company's technology licensing partner. The Guardian-LIFE medical patch is a derivative technology of GopherInsight™ microchip technology, which is currently licensed exclusively to the Company. The Guardian-LIFE technology is also to be licensed to the Company and such a license would represent a further expansion of the products licensed to the Company. The Guardian-LIFE technology represents a new sub-product of Guardian Patch LLC's Guardian Patch tracking technology.

The Guardian-LIFE technology is an electronic circuit within a sticky patch package is designed for human vital signs information detection and measurement. The Guardian-LIFE medical patch is based on an optical-acoustic laser technology. The medical patch detection and measurement device includes an affixed sensor system, an optical-acoustic sensing system, an analysis computerized system and a display unit. The user is intended to stick the patch against a human anatomical location for vital detection and measurements. The optical-acoustic system's data is analyzed by the computerized system to calculate and determine the human vital information and to present it on the display system. The system measures heart rate, a systolic blood pressure, a diastolic blood pressure, a mean arterial blood pressure, a pulse pressure and temperature.

The Guardian-LIFE electronic circuit embedded within the medical sticky patch includes a BIOS, ROM, RAM memory and at least one microprocessor or microcontroller. The electronic circuits are located within microchips or on the device's electronic board as separated microchips. The electronic circuit within the patch transmits the vital signs information via conventional network including Wi-Fi and Bluetooth. The system works in conjunction with a mobile software application to provide human vital detection and measurement functionalities within mobile devices and a web based application.

The Guardian Patch, the company's first exclusively licensed product to bring to the consumer markets, is a unique location technology that works with or without GPS. All of the technologies that are currently being developed by Guardian Patch LLC are currently based on GopherInsight™ microchip technology, which the Company exclusively holds a license to.


About Gopher Protocol Inc.
Gopher Protocol Inc. ("Gopher" and the "Company") (OTCQB: GOPH) (http://gopherprotocol.com/) is Development-stage Company that is developing a real-time, heuristic based, mobile technology, per license agreement it holds. Upon development, the technology will consist of a smart microchip, mobile application software and supporting software that run on a server. The system contemplates the creation of a global network, worldwide. Gopher believes this will be the first system that is developed using a human, heuristic based analysis engine. Since the core of the system will be its advanced microchip that will be able to be installed any mobile device, worldwide, Gopher expects that this will result in an internal, private network between all mobile devices utilizing the device by providing mobile technology for computing power enhancement, advanced mobile database management/sharing, and additional mobile features.

Corporate Site: http://gopherprotocol.com


Consumer and product website for Guardian Patch: http://www.guardianpatch.com/

Forward-Looking Statements
Certain statements contained in this press release may constitute "forward-looking statements". Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

Contact:
Dr. Dan Rittman, CTO
Gopher Protocol Inc.
888-685-7336

Visit this company: http://gopherprotocol.com/

More info on GOPH at Investorideas.com Visit: http://www.investorideas.com/CO/GOPH/

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Sign up for free news alerts

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GOPH is a PR , social media and publishing client and compensates Investorideas.com ( three months effective April 4, 2016- three thousand five hundred per month )


Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Thursday, April 21, 2016

Tech News: Gopher Protocol Inc. (OTCQB: $GOPH) Management to Be Guests on Upcoming K-TALK Radio Show on April 30th, 2016

Gopher Protocol Inc. (OTCQB: $GOPH) Management to Be Guests on Upcoming K-TALK Radio Show on April 30th, 2016

Wilkinson Financial Radio Show Will Host Discussion on Gopher Protocol's Proprietary Guardian Patch Tracking Technology, Which Does Not Require Conventional Network or GPS for Tracking



SAN DIEGO, CA - April 21, 2016 (Investorideas.com Newswire) Gopher Protocol Inc. (OTCQB: GOPH) ("Gopher" and the "Company"), a development-stage Company developing a real-time, heuristic based, mobile technology, announces to its shareholders and followers that the Company's management team will be featured guests on K-TALK Radio on April 30, 2016. In an in-depth segment to be aired from 10:00 a.m. to 12:00 p.m. (Mountain Time), Michael Murray, the Company's Chief Executive Officer, and Dr. Danny Rittman Ph.D., its Chief Technology Officer, will discuss Gopher Protocol's proprietary mobile tracking licensed technology.

K-TALK AM630 is the longest running talk radio station in the State of Utah and the third longest running talk radio station in the country. The Wilkinson Financial Radio Show shares stories and principles of entrepreneurship and business planning, with a goal of inspiring and educating listeners. (http://www.k-talk.com/)

The show will cover the history and background of the Company and its technology, the challenges to develop an innovative technology and bring it to market, and lastly, the potential future prospects for the Company.

As a component of the Company's licensed technology, the first product that is being developed by the Company is the Guardian Patch, an electronic circuit including a proprietary microchip technology that is within a sticky patch package. Guardian Patch can be affixed to any object, mobile or static, in order to track its location anywhere on earth. It does not require conventional network or GPS for tracking.

Dr. Danny Rittman Ph.D., Chief Technology Officer, said, "This show provides us with an opportunity to explain in great detail the unique features of Guardian Patch and how this sticky patch can be affixed to any object in order to track it anywhere. The fact that it can work with or without GPS makes it a game-changer."

About Gopher Protocol Inc.
Gopher Protocol Inc. ("Gopher" and the "Company") (OTCQB: GOPH) (http://gopherprotocol.com/) is Development-stage Company that is developing a real-time, heuristic based, mobile technology, per license agreement it holds. Upon development, the technology will consist of a smart microchip, mobile application software and supporting software that run on a server. The system contemplates the creation of a global network, worldwide. Gopher believes this will be the first system that is developed using a human, heuristic based analysis engine. Since the core of the system will be its advanced microchip that will be able to be installed any mobile device, worldwide, Gopher expects that this will result in an internal, private network between all mobile devices utilizing the device by providing mobile technology for computing power enhancement, advanced mobile database management/sharing, and additional mobile features.


Consumer and product website for Guardian Patch: http://www.guardianpatch.com/.


Forward-Looking Statements
Certain statements contained in this press release may constitute "forward-looking statements". Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

Contact:
Dr. Dan Rittman, CTO
Gopher Protocol Inc.
888-685-7336

Visit this company: http://gopherprotocol.com/

More info on GOPH at Investorideas.com Visit: http://www.investorideas.com/CO/GOPH/

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Sign up for free news alerts

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GOPH is a PR , social media and publishing client and compensates Investorideas.com ( three months effective April 4, 2016- three thousand five hundred per month )

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.